Cepheid (NASDAQ:CPHD)

CAPS Rating: 3 out of 5

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.

Recs

0
Player Avatar JohnStuartMill (70.87) Submitted: 2/8/2012 3:11:41 PM : Outperform Start Price: $43.17 CPHD Score: -12.73

The key to this companies success is right on their web site.

"All have our proven GeneXpert module at their analytic heart, and use the same patented cartridge technology for every Xpert® test. "

The GeneXpert module is a patented system which provides easy quick solutions using a simple to use cartridge technology.

Featured Broker Partners


Advertisement